← Elanco Animal Health Inc
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $474.8m | $334.0m | $494.7m | $638.0m | $345.0m | $352.0m | $468.0m | $545.0m | |
| Accounts receivable, net | $651.8m | $816.9m | $871.6m | $833.0m | $797.0m | $842.0m | $805.0m | $873.0m | |
| Other receivables | $57.6m | $73.0m | $205.1m | $195.0m | $205.0m | $168.0m | $81.0m | $67.0m | |
| Inventories | $1.0b | $1.1b | $1.6b | $1.4b | $1.5b | $1.7b | $1.6b | $1.7b | |
| Prepaid expenses and other | $113.9m | $87.4m | $256.3m | $237.0m | $394.0m | $310.0m | $287.0m | $236.0m | |
| Total current assets | $2.5b | $2.4b | $3.4b | $3.3b | $3.3b | $3.4b | $3.2b | $3.5b | |
| Property and equipment, net | $922.4m | $955.3m | $1.3b | $1.1b | $999.0m | $1.0b | $993.0m | $1.4b | |
| Goodwill | $3.0b | $3.0b | $6.2b | $6.2b | $6.0b | $5.1b | $4.4b | $4.8b | |
| Other intangibles, net | $2.5b | $2.5b | $6.4b | $5.6b | $4.8b | $4.5b | $3.7b | $3.4b | |
| Other noncurrent assets | $66.6m | $185.0m | $347.8m | $387.0m | $378.0m | $341.0m | $311.0m | $304.0m | |
| Employee compensation | $98.9m | $99.6m | $143.6m | $185.0m | $146.0m | $157.0m | $177.0m | $206.0m | |
| Sales rebates and discounts | $169.9m | $211.0m | $295.3m | $316.0m | $324.0m | $367.0m | $332.0m | $416.0m | |
| Other current liabilities | $199.0m | $244.4m | $576.9m | $430.0m | $454.0m | $409.0m | $466.0m | $533.0m | |
| Liability for sale of future revenue | — | — | — | — | — | — | $0 | $304.0m | |
| Deferred taxes | $114.6m | $100.8m | $900.3m | $745.0m | $662.0m | $567.0m | $449.0m | $382.0m | |
| Total equity | $5.2b | $5.5b | $8.5b | $7.5b | $7.3b | $6.2b | $6.1b | $6.5b | |
| Total assets | $9.0b | $9.0b | $17.7b | $16.5b | $15.5b | $14.4b | $12.6b | $13.4b | |
| Accounts payable | $205.2m | $222.6m | $501.0m | $418.0m | $390.0m | $270.0m | $296.0m | $368.0m | |
| Current portion of long-term debt and finance lease liability | $2.5b | $2.4b | $6.1b | $6.3b | $5.8b | $5.8b | $44.0m | $74.0m | |
| Accrued retirement benefits | $109.1m | $82.5m | $345.7m | $271.0m | $161.0m | $184.0m | $175.0m | $158.0m | |
| Total current liabilities | $970.7m | $818.5m | $2.1b | $1.6b | $1.7b | $1.2b | $1.3b | $1.6b | |
| Long-term debt and finance lease liability | — | — | — | — | — | — | $4.3b | $3.9b | |
| Other noncurrent liabilities | $121.5m | $106.6m | $322.1m | $261.0m | $229.0m | $411.0m | $302.0m | $427.0m | |
| Total liabilities | $3.8b | $3.4b | $9.2b | $8.9b | $8.2b | $8.1b | $6.5b | $6.8b | |
| Preferred stock, 1,000,000,000 shares authorized, no par value; none issued | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 | |
| Common stock, 5,000,000,000 shares authorized, no par value; 496,975,154 and 494,445,839 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | $5.4b | $5.6b | $8.7b | $8.7b | $8.7b | $8.8b | $8.8b | $8.9b | |
| Accumulated deficit | $16.4m | $84.3m | ($477.2m) | ($949.0m) | ($1.1b) | ($2.3b) | ($1.9b) | ($2.2b) | |
| Accumulated other comprehensive loss | ($222.2m) | ($173.7m) | $303.0m | ($209.0m) | ($392.0m) | ($266.0m) | ($771.0m) | ($141.0m) | |
| Total liabilities and equity | $9.0b | $9.0b | $17.7b | $16.5b | $15.5b | $14.4b | $12.6b | $13.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.